Letters Clostridium difficile

Improvement targets for C difficile must be valid

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39169.900475.1F (Published 05 April 2007) Cite this as: BMJ 2007;334:709
  1. M A Cooper, director, infection prevention and control1,
  2. P M Hawkey, consultant medical microbiologist (peter.hawkey@heartofengland.nhs.uk)2
  1. 1Royal Wolverhampton Hospitals NHS Trust, Department of Microbiology, New Cross Hospital, Wolverhampton WV10 0QP
  2. 2West Midlands Public Health Laboratory, Birmingham Heart of England NHS Trust, Birmingham B9 5SS

    We have identified a potentially distorting factor in the delivery of reductions in Clostridium difficile rates.1 A letter sent to chief executives of trusts, primary care trusts, and strategic health authorities in England in December 2006 stated that the forthcoming NHS operating framework for 2007-8 and the NHS contract require primary care trusts to agree a local target with their acute hospital providers for a significant reduction in C difficile infections.2 The target …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription